Companies
Amdocs Unveils AI Platform to Shake Up Telecom Legacy Systems
Shares down 24% year-to-date as the telecom software maker pivots to its aOS agentic platform, anchored by a landmark Liberty Latin America deal.
Entrada Therapeutics outlines data catalysts at Cantor Fitzgerald healthcare conference
Entrada Therapeutics detailed its endosomal escape platform, cash runway and upcoming trial readouts, while noting a $250 million upfront from Vertex and price targets of $11‑$25.
Trump Calls AI a Hoax During Surprise On-Stage Moment With Nvidia's Huang
President Trump unexpectedly called AI a hoax while on stage with Nvidia CEO Jensen Huang, raising questions about political risk for the chipmaker's growth trajectory.
Nvidia's AI Training Lead May Be Just the Start of a Larger Inference Opportunity
Analysts note that while Nvidia's GPUs dominate AI model training, the recurring demand for inference workloads could become a far larger market as AI agents see wider use.
NovoCure sees launch momentum across cancer franchises at Wells Fargo conference
Cancer therapy maker reports positive Q2 cash flow, strong Optune Pax uptake, and multiple regulatory milestones at Wells Fargo Healthcare Conference.
DBV Technologies Advances FDA Discussions on Peanut Allergy Patch VIASKIN
The biotech said it completed pivotal trials and held advanced discussions with the FDA on its BLA for VIASKIN Peanut. The company is seeking a capital raise ahead of commercialization.
CorMedix CFO highlights strong free cash flow, REZZAYO pathway at Wells Fargo healthcare conference
CorMedix reported $130 million in H1 free cash flow and 90% gross margins while outlining a path to FDA approval for prophylactic REZZAYO by early 2027.
National Bank of Canada charts disciplined growth path at Scotiabank summit
CEO Laurent set capital and return targets while warning about U.S. trade tensions and drawing firm lines on AI use in lending and pricing decisions.
NCCN Names clonoSEQ for MRD in Updated Multiple Myeloma Guidelines
The National Comprehensive Cancer Network added a dedicated MRD testing page to its multiple myeloma guidelines, singling out Adaptive Biotechnologies' clonoSEQ assay.
ZenaTech qualifies for Canada defense drone marketplace
ZenaTech Inc. won a spot in the Government of Canada's pre-qualified supplier pool for drones supporting military and coast guard operations.
Five Below Turnaround Gains Momentum on Store Growth, Margin Expansion
Five Below raised its 2026 operating margin outlook to about 12.5% and announced a $600 million share buyback as CEO Winnie Park detailed expanding store rollout and sustained double-digit comp growth.
Allergan Aesthetics Reports Skincare Study Data for Weight-Loss Patients
Two small trials presented at the Science of Skin Summit show improved skin quality and reduced apparent age in patients taking GLP-1 weight-loss medications.
World Kinect founder Kasbar steps down as chairman, Bakshi takes over
Founder Michael J. Kasbar will step down as executive chairman of the global fuel supplier by Dec. 31, with independent director Ken Bakshi named to replace him at a company that serves more than 200 countries.
Lucid, Bolt Partner to Deploy Autonomous Vehicles Across Europe
Lucid Group and mobility firm Bolt announced a partnership to deploy Level 4 autonomous ridesharing fleets in Europe, with Bolt targeting 25,000 Lucid Midsize vehicles.
Apple announces iPhone 18 Pro and iPhone 18 Pro Max
Apple has announced the iPhone 18 Pro and iPhone 18 Pro Max.
Zscaler unveils Agentic SOC and AI security suite, raises FY27 guidance
At the Goldman Sachs Communacopia + Technology Conference, Zscaler announced its Agentic SOC platform, AI‑focused security tools and lifted its full‑year 2027 outlook.
TG Therapeutics BRIUMVI Close to $1B Run Rate at Cantor Conference
TG Therapeutics chairman Mike Weiss said BRIUMVI IV is tracking toward a $1 billion annual run rate by year-end 2024, with subQ sales seen as potentially double the current franchise.
Kinaxis Details AI Rollout and Growth Strategy at Citi Tech Conference
Supply-chain software maker Kinaxis outlined its three-phase AI deployment plan and reported H1 2024 SaaS and ARR growth of about 20% year-over-year at Citi's 2026 Global TMT Conference.
Teradata highlights cloud, AI and hybrid strategy at Citi 2026 TMT conference
CEO Steve McMillan says roughly half of Teradata’s recurring revenue now derives from cloud services and outlines new AI‑driven products and a hybrid compute engine.
Leidos Broadens Growth Beyond Defense at Jefferies Industrials Conference
Leidos raises full-year organic-growth guidance to roughly 8% in the second half of 2024, citing momentum across defense, energy infrastructure, and health segments despite headwinds in Veterans Affairs medical-disability exams.
APi Group Targets $10B Revenue as Data Center Demand Fuels Expansion
Elevator and inspection services company APi Group said data centers are driving unprecedented demand, with a record $5B+ backlog and 2028 revenue target of $10 billion.
European Commission proposes simpler public tender rules and 'Buy European' criteria to reduce foreign dependence
The European Commission has announced a proposal to simplify public tender procedures and introduce a 'Buy European' criterion to lessen reliance on foreign suppliers.
Lexicon Pharmaceuticals outlines HCM data timeline, T1D resubmission at Citi summit
The biotech firm highlighted its Q1 2027 readout target for the SONATA-HCM trial and a Q4 2024 resubmission for sotagliflozin’s type 1 diabetes indication, while detailing the Novo Nordisk partnership and an AI-driven drug discovery initiative.
Nuvation Bio outlines growth strategy built on Ibtrozi, glioma candidate and DDC platform
The biotech reported $700M cash and $170M TTM revenue at the Citigroup summit, while showcasing clinical data for its ROS1 lung-cancer drug and safusidenib glioma candidate.